EIHA projects GmbH, together with ChemSafe, their scientific provider, announced that they have submitted Novel Foods applications for natural CBD isolate and Full Spectrum; fully meeting the Food Safety Authority (FSA) deadline.... read more →
Synthetic cannabinoids are often regarded as a lower-quality alternative, but often they surpass natural compounds in terms of product quality and purity, Professor Edvinas Orentas, head of research at Sanobiotec, argues here. ... read more →
Positive regulatory developments are aiding the growth of the cannabis pharmaceuticals market, but more clinical data are needed to break the stigma and bring science to the fore.... read more →
Out of more than a hundred cannabinoids that have so far been identified in the cannabis sativa plant, the non-intoxicating cannabidivarin (CBDV)... read more →
It is hoped that the pure ingredient will open up new research prospects for pharma, wellness industry, and other market players.
... read more →
The question of how to achieve greater bioavailability of cannabinoids has been one of the main challenges for researchers in the cannabis industry, and for a good reason.... read more →
If you check out the biotechnology sector overview on Go Vilnius website, you might notice a familiar name – #Sanobiotec among fellow biotech companies operating from Vilnius. ... read more →
Sanobiotec aims to improve the technological processes for production of these compounds and leverage their therapeutic benefits for pharmaceuticals, wellness industry and treatment of progressive illnesses, such as cancer or Alzheimer’s.... read more →
The cannabinoids THC and CBD are the most prominent compounds in the cannabis industry and are well-known for their health benefits.... read more →
For 2020, the BIO International Convention will transition to a new, virtual event format, BIO Digital. This virtual gathering of the global biotech industry provides access... read more →